TROVE2 anticorps (AA 331-430) (Cy7)
-
- Antigène Voir toutes TROVE2 Anticorps
- TROVE2 (TROVE Domain Family, Member 2 (TROVE2))
-
Épitope
- AA 331-430
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TROVE2 est conjugé à/à la Cy7
-
Application
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human TROVE-2/SSA2
- Isotype
- IgG
- Top Product
- Discover our top product TROVE2 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- TROVE2 (TROVE Domain Family, Member 2 (TROVE2))
- Autre désignation
- TROVE-2 (TROVE2 Produits)
- Synonymes
- anticorps SSA2, anticorps TROVE2, anticorps ssa2, anticorps ssa2-A, anticorps RO60, anticorps RORNP, anticorps 1810007I17Rik, anticorps A530054J02Rik, anticorps AI646302, anticorps SS-A/Ro, anticorps Ssa, anticorps Ssa2, anticorps TROVE domain family member 2, anticorps TROVE domain family, member 2, anticorps TROVE domain family member 2 L homeolog, anticorps TROVE2, anticorps trove2, anticorps trove2.L, anticorps Trove2
- Sujet
-
Synonyms: TROVE2, 60 kDa ribonucleoprotein Ro, 60 kDa Ro protein, 60 kDa SS A/Ro ribonucleoprotein, 60 kDa SS-A/Ro ribonucleoprotein, Autoantigen Ro/SSA, 60-KD, bA101E13.2, Gastric cancer multi drug resistance protein, Ribonucleoprotein autoantigen SS A/Ro, RO 60, Ro 60 kDa autoantigen, RO60, RO60_HUMAN, RoRNP, Sjoegren syndrome antigen A2, Sjoegren syndrome type A antigen, Sjogren syndrome antigen A2 60kD ribonucleoprotein autoantigen SS A/Ro, Sjogren syndrome antigen A2 60 kDa ribonucleoprotein autoantigen SS A/Ro, Sjogren syndrome antigen A2, SS A, SS-A, SS-A/Ro, SSA 2, SSA, SSA2, TROVE 2, TROVE domain family member 2, TROVE2.
Background: Ro autoantigens are of clinical significance because directed against them are found in most patients with primary Sjqgren syndrome, subacute cutaneous lupus erythematosus (SLE), neonatal lupus erythematosus, ANA-negative lupus erythematosus, and systemic lupus erythematosus-like disease secondary to homozygous C2 or C4 complement deficiency (1). Ro/SSA is a ribonucleoprotein that binds to auto in 35 to 50 % of patients with SLE and in up to 97 % of patients with Sjqgren syndrome (2). The Ro/SSA particle consists of a single immunoreactive protein noncovalently bound with one of four small RNA molecules (2). Most anti-Ro/SSA-positive sera detect not only the main protein, but also a smaller Ro/SSA protein (2). The genes which encode the smaller and larger proteins map to human chromosomes 11p15.5 and 1q31, respectively (3?). La/SSB is an autoimmune RNA-binding protein that plays a role in the transcription of RNA polymerase III was originally defined by its reactivity with auto from patients with Sjren syndrome and SLE (6).
-